The CyberKnife Robotic Radiosurgery System is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas, and kidney. The treatment—which delivers high doses of radiation to tumors with extreme accuracy—offers new hope to patients who have inoperable or surgically complex tumors, or who may be looking for a non-surgical option. To date, more than 50,000 patients have been treated and more than 150 CyberKnife systems are installed worldwide.

Initially, radiosurgery was used to treat brain tumors; when technical improvements allowed for radiosurgery to be used anywhere in the body, the possible treatment sites were expanded to include cancer involving the spine. With more experience and further improvements in targeting tumors, the possible sites or types of cancers that may benefit have expanded dramatically.

The most common sites are noted below:

  • Benign Tumors

  • Brain

  • Colon

  • Head and Neck

  • Kidney

  • Liver

  • Lung

  • Metastases

  • Pancreas

  • Prostate

  • Spine

While most inoperable areas of the body can be treated with CyberKnife safely, the most common treatments are for:

  • Acoustic Neuroma

  • Arteriovenous Malformations (AVM)

  • Astrocytoma

  • Bladder Cancer

  • Brain Cancer – primary, multiple, and metastases can be treated in one session

  • Cavernous Sinus Tumors

  • Colon Cancer

  • Glioma

  • Head and Neck Cancer

  • Kidney (Renal) Cancer

  • Liver (Hepatocellular) Cancer – primary and metastatic

  • Lung Cancer – primary and metastatic

  • Meningioma

  • Osteosarcoma

  • Pancreatic Cancer

  • Parasellar Meningioma

  • Pituitary Adenoma

  • Prostate Cancer

  • Rectal and Anal Tumors and Cancer

  • Skeletal Metastases

  • Solitary Lymph Node

  • Spinal Cord and Nerves – benign and malignant tumors

  • Spinal Cord Tumors – Cervical, Thoracic, Lumbar, and Sacral Spine – primary and metastatic

  • Spinal Cord Tumors – Intradural and Intramedullary

  • Trigeminal Neuralgia

(Breast cancer treatment is in the clinical review process.)